STOCK TITAN

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) will participate in several investor conferences in September 2022. Notable events include the Citi 17th Annual BioPharma Conference on September 7 at 1:00 p.m. ET, the Wells Fargo Healthcare Conference on September 8 at 1:55 p.m. ET, the Baird 2022 Global Healthcare Conference on September 14 at 3:10 p.m. ET, and the BofA Global Research Healthcare Conference on September 16 at 10:05 a.m. ET. Webcasts will be available on their website for 30 days post-event.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences in September:

  • Citi 17th Annual BioPharma Conference: Fireside chat on Wednesday, September 7, 2022 at 1:00 p.m. ET.

  • Wells Fargo Healthcare Conference: Fireside chat on Thursday, September 8, 2022 at 1:55 p.m. ET.

  • Baird 2022 Global Healthcare Conference: Presentation on Wednesday, September 14, 2022 at 3:10 p.m. ET.

  • BofA Global Research Global Healthcare Conference 2022: Presentation on Friday, September 16, 2022 at 3:05 p.m. BST / 10:05 a.m. ET.

The conference events will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. Replays of the webcasts will be available for 30 days following the event.

About Apellis 
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in complement, we ushered in the first new class of complement medicine in 15 years with the approval of the first and only targeted C3 therapy. We are advancing this science to continually develop transformative medicines for people living with rare, retinal, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178


FAQ

When is Apellis Pharmaceuticals participating in the Citi 17th Annual BioPharma Conference?

Apellis Pharmaceuticals will participate in the Citi 17th Annual BioPharma Conference on September 7, 2022, at 1:00 p.m. ET.

What time is the Wells Fargo Healthcare Conference presentation by APLS?

The Wells Fargo Healthcare Conference presentation by Apellis Pharmaceuticals is scheduled for September 8, 2022, at 1:55 p.m. ET.

When will Apellis present at the Baird 2022 Global Healthcare Conference?

Apellis Pharmaceuticals will present at the Baird 2022 Global Healthcare Conference on September 14, 2022, at 3:10 p.m. ET.

What is the date and time for APLS's presentation at the BofA Global Research Healthcare Conference?

The presentation by Apellis Pharmaceuticals at the BofA Global Research Healthcare Conference is set for September 16, 2022, at 10:05 a.m. ET.

Where can I watch the webcasts of Apellis Pharmaceuticals' conference presentations?

You can watch the webcasts of Apellis Pharmaceuticals' conference presentations on the 'Events and Presentations' page of their website.

Apellis Pharmaceuticals, Inc.

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Stock Data

3.66B
105.50M
13.98%
97.43%
16.71%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WALTHAM